Imperative Care

Executive Summary

Imperative Care is a privately held medical device company dedicated to transforming the treatment of stroke and other vascular diseases. Founded in 2016 and headquartered in Campbell, California, the company has developed a portfolio of thrombectomy systems for ischemic stroke and peripheral vascular conditions. Additionally, Imperative Care is advancing a robotic platform designed to expand procedural access and precision. By addressing critical gaps across the entire patient journey—from acute intervention to long-term management—the company aims to improve outcomes for patients suffering from devastating vascular events. With a focus on innovation and clinical impact, Imperative Care has built a strong intellectual property position and is poised to capture significant market share in the neurovascular and peripheral vascular device markets. The company's robotic platform represents a key differentiator, potentially enabling broader adoption of minimally invasive procedures. As the company progresses through regulatory milestones and clinical validations, it is well-positioned for growth, though further funding or strategic partnerships may be required to fully commercialize its pipeline.

Upcoming Catalysts (preview)

• Q3 2026FDA Clearance for Next-Generation Thrombectomy System70% success
• TBDPivotal Clinical Trial Results for Robotic Platform60% success
• Q2 2026Strategic Partnership or Series C Financing75% success